258 related articles for article (PubMed ID: 26537119)
21. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
22. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
23. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metformin in cancers: An updated meta-analysis based on 80 cohort studies.
Yang J; Yang H; Cao L; Yin Y; Shen Y; Zhu W
Medicine (Baltimore); 2022 Dec; 101(49):e31799. PubMed ID: 36626437
[TBL] [Abstract][Full Text] [Related]
25. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
[TBL] [Abstract][Full Text] [Related]
26. Association between metformin use and risk of prostate cancer and its grade.
Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
[TBL] [Abstract][Full Text] [Related]
27. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
[TBL] [Abstract][Full Text] [Related]
28. A meta-analysis of diabetes mellitus and the risk of prostate cancer.
Kasper JS; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2056-62. PubMed ID: 17119028
[TBL] [Abstract][Full Text] [Related]
29. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Fajkovic H; Babjuk M; Kautzky-Willer A; Bachmann A; Scherr DS; Shariat SF
BJU Int; 2013 Dec; 112(8):1105-12. PubMed ID: 24053906
[TBL] [Abstract][Full Text] [Related]
30. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
31. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
He K; Hu H; Ye S; Wang H; Cui R; Yi L
Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
[TBL] [Abstract][Full Text] [Related]
32. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
[TBL] [Abstract][Full Text] [Related]
33. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
Zanders MM; Vissers PA; van de Poll-Franse LV
J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
[No Abstract] [Full Text] [Related]
34. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
35. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
36. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Taneja SS
J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
[No Abstract] [Full Text] [Related]
37. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
Weckermann D
Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
[No Abstract] [Full Text] [Related]
38. Metformin use and prostate cancer risk: A meta-analysis of cohort studies.
Feng Z; Zhou X; Liu N; Wang J; Chen X; Xu X
Medicine (Baltimore); 2019 Mar; 98(12):e14955. PubMed ID: 30896668
[TBL] [Abstract][Full Text] [Related]
39. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
40. Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh PP; Singh AG; Murad MH; McWilliams RR; Chari ST
Am J Gastroenterol; 2013 Apr; 108(4):510-9; quiz 520. PubMed ID: 23399556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]